Interaction between brain cell proteins could lead to new schizophrenia treatments
Improved schizophrenia therapies might soon be possible thanks to new university research that discovered a connection between the interactions of two brain cell proteins — MAP6 and Kv3.1 — and their role in the development of the disease.